A detailed history of New York State Common Retirement Fund transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New York State Common Retirement Fund holds 2,754,109 shares of BMY stock, worth $146 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,754,109
Previous 2,744,819 0.34%
Holding current value
$146 Million
Previous $149 Million 23.16%
% of portfolio
0.15%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $373,922 - $492,277
9,290 Added 0.34%
2,754,109 $114 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $3.71 Million - $4.21 Million
-77,378 Reduced 2.74%
2,744,819 $149 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $17.6 Million - $21 Million
-363,470 Reduced 11.41%
2,822,197 $145 Million
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $12.9 Million - $14.4 Million
-223,043 Reduced 6.54%
3,185,667 $185 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $10 Million - $11.1 Million
-156,907 Reduced 4.4%
3,408,710 $218 Million
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $12.7 Million - $14.4 Million
-193,768 Reduced 5.15%
3,565,617 $247 Million
Q4 2022

Jan 30, 2023

SELL
$68.48 - $81.09 $40,129 - $47,518
-586 Reduced 0.02%
3,759,385 $270 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $21,564 - $12.7 Million
-165,877 Reduced 4.23%
3,759,971 $267 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $9.56 Million - $10.5 Million
-131,604 Reduced 3.24%
3,925,848 $302 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $3.39 Million - $4.06 Million
-55,134 Reduced 1.34%
4,057,452 $296 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $542,842 - $632,827
10,122 Added 0.25%
4,112,586 $256 Million
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $14.1 Million - $16.5 Million
-238,580 Reduced 5.5%
4,102,464 $243 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $6.05 Million - $6.59 Million
-97,738 Reduced 2.2%
4,341,044 $290 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $9.97 Million - $11.2 Million
-167,962 Reduced 3.65%
4,438,782 $280 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $13.7 Million - $15.5 Million
-237,333 Reduced 4.9%
4,606,744 $286 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $16.5 Million - $18.2 Million
-286,700 Reduced 5.59%
4,844,077 $292 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $17.4 Million - $20.3 Million
-316,970 Reduced 5.82%
5,130,777 $302 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $2.24 Million - $3.25 Million
-48,200 Reduced 0.88%
5,447,747 $304 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $74.6 Million - $97.3 Million
1,515,047 Added 38.06%
5,495,947 $353 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $4.39 Million - $5.2 Million
102,578 Added 2.64%
3,980,900 $202 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $4.59 Million - $5.08 Million
-102,978 Reduced 2.59%
3,878,322 $176 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $446,688 - $532,620
9,900 Added 0.25%
3,981,300 $190 Million
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $6.92 Million - $8.98 Million
-141,990 Reduced 3.45%
3,971,400 $206 Million
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $2.8 Million - $3.15 Million
-50,650 Reduced 1.22%
4,113,390 $255 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $8.8 Million - $11 Million
-174,145 Reduced 4.01%
4,164,040 $230 Million
Q1 2018

May 10, 2018

SELL
$59.92 - $68.98 $4.81 Million - $5.54 Million
-80,337 Reduced 1.82%
4,338,185 $274 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $3.63 Million - $3.96 Million
60,547 Added 1.39%
4,418,522 $271 Million
Q3 2017

Nov 06, 2017

SELL
$55.23 - $63.74 $6.62 Million - $7.64 Million
-119,850 Reduced 2.68%
4,357,975 $278 Million
Q2 2017

Aug 11, 2017

BUY
N/A
4,477,825
4,477,825 $250 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.